Altimmune, Inc. Revenue 2010–2025
Altimmune, Inc. annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Altimmune, Inc. revenue for the quarter ending September 30, 2025 was 5000, a 0.00% increase year-over-year.
- Altimmune, Inc. revenue for the twelve months ending September 30, 2025 was 20000, a 94.71% decrease year-over-year.
- Altimmune, Inc. annual revenue for 2025 was 41000, a 105.00% increase from 2024.
- Altimmune, Inc. annual revenue for 2024 was 20000, a 95.31% decrease from 2023.
- Altimmune, Inc. annual revenue for 2023 was 426000, a 726.47% decrease from 2022.
- Altimmune, Inc. annual revenue for 2022 was -68000.
Altimmune, Inc. (ALT) — Frequently Asked Questions
Altimmune, Inc. (ALT) is a publicly traded US company. It has a market capitalization of $229M. In fiscal 2025 it reported revenue of $41,000 and net income of -$88M. Explore ALT's stock price, financial statements, earnings history, margins and key ratios below.
What is Altimmune, Inc.'s market cap?
Altimmune, Inc. (ALT) has a market capitalization of $229M.
What is the ALT stock price?
ALT trades at $2.60 (-0.38% on the day).
How much revenue does Altimmune, Inc. make?
Altimmune, Inc. reported revenue of $41,000 in fiscal 2025.
Is ALT profitable?
In fiscal 2025, Altimmune, Inc. reported net income of -$88M.